Business
DBV Technologies S.A.: "Viaskin" and our other registered and common law trade names, trademarks and service marks are the property of DBV Technologies S.A. or our subsidiaries.
Revenue increased 35.8% to $5.6M, while Net income decreased 29.0% to ($146.9M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $5.6MWatch
- Profitability — Net income ($146.9M)Watch
- Cash generation — Free cash flow ($121.7M)Note
- Accounting — Formula distress score · manipulation and earnings-quality screens not computedWatch
- Insiders — 0 buys; 5 sells in 365 daysNote
- Capital — Comparable payout data unavailableNote
Leadership changes
From DBV Technologies S.A.'s own filings, the day they're filed.
- Philina Lee · Directors · departureeff. 2025-10-30
- Daniel Soland · Directors · departureeff. 2025-09-18
- Continued Employment Condition · departure
Latest filings
- 10-Q · Quarterly report2026-07-16
- 8-K · Company announcement2026-07-16
- 8-K · Company announcement2026-06-29
- 8-K · Company announcement2026-06-05
- 8-K · Company announcement2026-06-03
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about DBV Technologies S.A., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.